This emerging multibillion-dollar industry is in the process of significant regulatory and legal reform that offers explosive growth opportunities to participants. Currently the industry as a whole is highly fragmented with significant changes scheduled for April 1, 2014, as stated on the Health Canada website. Supreme has been approached as a vehicle to consolidate fragmented growers and work with dispensaries to obtain the new marijuana for medical purposes regulations (MMPR) licence. Currently management is reviewing a number of business plans and proposals as well as adding industry expertise to its advisory board.
SPRWF has a big advantage over a lot of these marijuana stocks. The CEO and President David Stadnyk, has a lot of experience with pharmaceutical companies.